Clinical Trial of Recombinant Human Papillomavirus Virus 16/18 Bivalent Vaccine

Inclusion Criteria:

• Written informed consent from the subject prior to enrolment;
• Female between, and including, 18 and 55 years of age at the time of enrolment;
• Subjects must be free of obvious health problems;
• Not pregnant and having no plan for pregnancy;

Exclusion Criteria:

• Pregnant or breastfeeding or having plan for pregnancy during the whole study (Month 0-7);
• Previous vaccination against HPV;
• Having severe allergic history or other immunodeficiency;
• Chemotherapy and other immunosuppressive agents using;